Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1011 | 1044 | 1083 | 1025 | 1144 | 1446 |
Fund Return | 1.06% | 4.42% | 8.3% | 0.82% | 2.73% | 3.76% |
Place in category | 2346 | 2222 | 1414 | 1563 | 1144 | 325 |
% in Category | 77 | 69 | 48 | 65 | 55 | 29 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Nordea Invest Basis 3 Acc | 12.05B | 2.90 | 3.78 | 6.03 | ||
Nordea Invest Global Stars | 2.98B | 5.94 | 7.52 | 11.04 | ||
Nordea Invest Global Enhanced | 5.86B | 8.35 | 14.67 | - | ||
Nordea Invest Emerging Markets | 3.35B | 6.07 | -1.21 | 5.96 | ||
Nordea Invest Globale Aktier Indeks | 2.57B | 16.65 | 9.27 | 11.40 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LD Aktier Obligationer | 21.89B | 5.98 | 3.16 | 4.35 | ||
Sparinvest SICAV Balance DKK R | 2.46B | 6.73 | 1.68 | 3.41 | ||
Jyske Portefolje Balanceret Akk KL | 14.18B | 7.52 | 1.58 | 3.66 | ||
Nordea Invest Basis 3 Acc | 12.05B | 2.90 | 3.78 | 6.03 | ||
PFA Invest Balance B | 6.15B | 9.24 | 3.11 | 6.20 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Nordea 2 - US Corp Enhanced Bd HY DKK | LU2084122212 | 6.58 | - | - | |
Nordea 1 - European Corporate Bd Y EUR | LU0994713799 | 5.29 | - | - | |
Nordea Invest Engros Absolute Return Equities II | DK0060039824 | 4.25 | 118.500 | -0.60% | |
Realkredit Danmark A/S 1% | DK0009295222 | 4.15 | - | - | |
Realkredit Danmark A/S 1% | DK0009299729 | 4.06 | - | - |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review